Medical insurance should become very attractive to middle-class families in China because they really don't want to undertake that risk themselves.

223

The prices of any vehicles ordered based on the old price but not yet delivered would be adjusted according to the new prices that will be announced later.

127

Taking a long-term view, we fully expect China's eventual emergence as a full-fledged R&D hub in any global network. Capabilities in chemistry and clinical research are already well established with great potential for rapid growth in biology and preclinical development.

77

The decision how and when to invest in R&D in China is a strategic choice. By investing more heavily and in more complex areas of R&D in China, an MPC can signal its commitment to the Chinese market and strengthen relationships with key opinion leaders and officials there -- thus increasing its chances of thriving in the health care market now taking shape in China.

72